OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
Raquel S. Laureano, Jenny Sprooten, Isaure Vanmeerbeerk, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 91
Raquel S. Laureano, Jenny Sprooten, Isaure Vanmeerbeerk, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 91
Showing 1-25 of 91 citing articles:
Dendritic cells as orchestrators of anticancer immunity and immunotherapy
Ignacio Heras‐Murillo, Irene Adán‐Barrientos, Miguel Á. Galán, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 257-277
Closed Access | Times Cited: 98
Ignacio Heras‐Murillo, Irene Adán‐Barrientos, Miguel Á. Galán, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 257-277
Closed Access | Times Cited: 98
Trial watch: chemotherapy-induced immunogenic cell death in oncology
Jenny Sprooten, Raquel S. Laureano, Isaure Vanmeerbeek, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 42
Jenny Sprooten, Raquel S. Laureano, Isaure Vanmeerbeek, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 42
Dendritic Cells in Cancer Immunology and Immunotherapy
Laura Hato, Ángel Vizcay Atienza, Iñaki Eguren, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 981-981
Open Access | Times Cited: 40
Laura Hato, Ángel Vizcay Atienza, Iñaki Eguren, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 981-981
Open Access | Times Cited: 40
Lymph node and tumor-associated PD-L1+ macrophages antagonize dendritic cell vaccines by suppressing CD8+ T cells
Jenny Sprooten, Isaure Vanmeerbeek, Angeliki Datsi, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 1, pp. 101377-101377
Open Access | Times Cited: 19
Jenny Sprooten, Isaure Vanmeerbeek, Angeliki Datsi, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 1, pp. 101377-101377
Open Access | Times Cited: 19
The tumor microenvironment and dendritic cells: Developers of pioneering strategies in colorectal cancer immunotherapy?
Farid Ghorbaninezhad, Mina Afrashteh Nour, Omid Rahbar Farzam, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189281-189281
Closed Access | Times Cited: 2
Farid Ghorbaninezhad, Mina Afrashteh Nour, Omid Rahbar Farzam, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189281-189281
Closed Access | Times Cited: 2
Living Leukocyte‐Based Drug Delivery Systems
Yaxin Chen, Duotian Qin, Jianhua Zou, et al.
Advanced Materials (2022) Vol. 35, Iss. 17
Closed Access | Times Cited: 60
Yaxin Chen, Duotian Qin, Jianhua Zou, et al.
Advanced Materials (2022) Vol. 35, Iss. 17
Closed Access | Times Cited: 60
The future of affordable cancer immunotherapy
Niels Schaft, Jan Dörrie, Gerold Schuler, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 39
Niels Schaft, Jan Dörrie, Gerold Schuler, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 39
Immunotargeting of Cancer Stem Cells
Ayşe Sedef Köseer, Simona Di Gaetano, Claudia Arndt, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1608-1608
Open Access | Times Cited: 29
Ayşe Sedef Köseer, Simona Di Gaetano, Claudia Arndt, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1608-1608
Open Access | Times Cited: 29
Nanotechnology Meets Stem Cell Therapy for Treating Glioblastomas: A Review
Anup K. Ghosh, Aparajita Ghosh, Prasanta Kumar Das
ACS Applied Nano Materials (2024) Vol. 7, Iss. 3, pp. 2430-2460
Closed Access | Times Cited: 12
Anup K. Ghosh, Aparajita Ghosh, Prasanta Kumar Das
ACS Applied Nano Materials (2024) Vol. 7, Iss. 3, pp. 2430-2460
Closed Access | Times Cited: 12
The role of dendritic cells in cancer immunity and therapeutic strategies
Yunze Tai, Man Chen, Fang Wang, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111548-111548
Closed Access | Times Cited: 11
Yunze Tai, Man Chen, Fang Wang, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111548-111548
Closed Access | Times Cited: 11
New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication
Sha Qin, Bin Xie, Qingyi Wang, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 10
Sha Qin, Bin Xie, Qingyi Wang, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 10
Trial watch: bispecific antibodies for the treatment of relapsed or refractory large B-cell lymphoma
Giulio Cassanello, Alejandro Luna, Lorenzo Falchi
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Giulio Cassanello, Alejandro Luna, Lorenzo Falchi
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Trial watch: dexmedetomidine in cancer therapy
Killian Carnet Le Provost, Oliver Kepp, Guido Kroemer, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Killian Carnet Le Provost, Oliver Kepp, Guido Kroemer, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Recent Advances in Biomimetic Strategies for the Immunotherapy of Glioblastoma
Haoyu You, Shuo Geng, Shangkuo Li, et al.
Biomaterials (2024) Vol. 311, pp. 122694-122694
Closed Access | Times Cited: 8
Haoyu You, Shuo Geng, Shangkuo Li, et al.
Biomaterials (2024) Vol. 311, pp. 122694-122694
Closed Access | Times Cited: 8
Dendritic cells in triple-negative breast cancer: From pathophysiology to therapeutic applications
Ana Isabel Sebastião, Gabriel Chahade Sibanto Simões, Filomena Oliveira, et al.
Cancer Treatment Reviews (2025) Vol. 133, pp. 102884-102884
Open Access | Times Cited: 1
Ana Isabel Sebastião, Gabriel Chahade Sibanto Simões, Filomena Oliveira, et al.
Cancer Treatment Reviews (2025) Vol. 133, pp. 102884-102884
Open Access | Times Cited: 1
Current Status and Challenges of Vaccination Therapy for Glioblastoma
Hamed Hosseinalizadeh, Mohammad Rahmati, Ammar Ebrahimi, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 4, pp. 435-446
Closed Access | Times Cited: 14
Hamed Hosseinalizadeh, Mohammad Rahmati, Ammar Ebrahimi, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 4, pp. 435-446
Closed Access | Times Cited: 14
Challenges in tolerogenic dendritic cell therapy for autoimmune diseases: the route of administration
María José Mansilla, Catharien M. U. Hilkens, Eva Martínez‐Cáceres
Immunotherapy Advances (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 14
María José Mansilla, Catharien M. U. Hilkens, Eva Martínez‐Cáceres
Immunotherapy Advances (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 14
Advances in Cancer Vaccine Research
Nian Liu, Xiangyu Xiao, Zi-qiang Zhang, et al.
ACS Biomaterials Science & Engineering (2023) Vol. 9, Iss. 11, pp. 5999-6023
Closed Access | Times Cited: 14
Nian Liu, Xiangyu Xiao, Zi-qiang Zhang, et al.
ACS Biomaterials Science & Engineering (2023) Vol. 9, Iss. 11, pp. 5999-6023
Closed Access | Times Cited: 14
Overcoming Suppressive Tumor Microenvironment by Vaccines in Solid Tumor
Ya‐Jia Xie, Wen-Qian Liu, Dan Li, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 394-394
Open Access | Times Cited: 13
Ya‐Jia Xie, Wen-Qian Liu, Dan Li, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 394-394
Open Access | Times Cited: 13
Integrating immunopeptidome analysis for the design and development of cancer vaccines
Sara Feola, Jacopo Chiaro, Vincenzo Cerullo
Seminars in Immunology (2023) Vol. 67, pp. 101750-101750
Open Access | Times Cited: 13
Sara Feola, Jacopo Chiaro, Vincenzo Cerullo
Seminars in Immunology (2023) Vol. 67, pp. 101750-101750
Open Access | Times Cited: 13
Targeted demethylation and activation of NLRC5 augment cancer immunogenicity through MHC class I
Xin Sun, Toshiyuki Watanabe, Yoshitaka Oda, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 6
Open Access | Times Cited: 5
Xin Sun, Toshiyuki Watanabe, Yoshitaka Oda, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 6
Open Access | Times Cited: 5
Neo-BCV: A Novel Bacterial Liquid Complex Vaccine for Enhancing Dendritic Cell-Mediated Immune Responses Against Lung Cancer
Zilong Zhu, Zhuze Chu, Fei Fei, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 64-64
Open Access
Zilong Zhu, Zhuze Chu, Fei Fei, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 64-64
Open Access
Revolutionizing cancer treatment: The power of dendritic cell-based vaccines in immunotherapy
Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Reza Heidari, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117858-117858
Closed Access
Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Reza Heidari, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117858-117858
Closed Access
Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy
Fatemeh Sadat Toghraie, Maryam Bayat, Mahsa Sadat Hosseini, et al.
Cellular Oncology (2025)
Open Access
Fatemeh Sadat Toghraie, Maryam Bayat, Mahsa Sadat Hosseini, et al.
Cellular Oncology (2025)
Open Access
Gold Nanoparticles Synthesized with Triple-Negative Breast Cancer Cell Lysate Enhance Antitumoral Immunity: A Novel Synthesis Method
Raúl Rangel‐López, Moisés Ármides Franco-Molina, Cristina Rodríguez‐Padilla, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 330-330
Open Access
Raúl Rangel‐López, Moisés Ármides Franco-Molina, Cristina Rodríguez‐Padilla, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 330-330
Open Access
